Dexil

Quick links to important sections

Dexil

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dexil

Property Description
Active ingredient Dexchlorpheniramine Maleate
Form Oral tablet, oral syrup
Pharmacological class Antihistamine (First-generation H1 antagonist)
Common use Symptomatic relief of allergy
Origin Synthetic compound

What is Dexil and its Pharmacological Class?

Dexil is a pharmaceutical preparation containing the active ingredient Dexchlorpheniramine Maleate. This classification as a first-generation H1 receptor antagonist places it within the larger therapeutic category of antihistamines. This medicine is a synthetic compound, chemically defined by its distinctive characteristic as the isolated dextrorotatory isomer of the older substance chlorpheniramine. This precise chemical structure and its systemic action profile define it as a potent single-entity agent intended to block allergic responses throughout the body.

Composition and Available Dosage Forms

The composition of Dexil is centered solely on the active entity, Dexchlorpheniramine Maleate, rather than a combination of ingredients. This single-ingredient product is designed for the oral route of administration and is commonly supplied as standardized oral tablets and oral syrup. The formulation includes necessary pharmaceutical excipients to ensure the stable and effective delivery of the drug. The availability in both liquid syrup and solid tablet forms accommodates the varying needs of both adult and pediatric patients who require different methods of oral consumption.

General Therapeutic Role of Dexil

The general purpose of Dexil is to provide symptomatic relief for the physical manifestations associated with common allergic reactions. This substance is intended specifically to alleviate common allergic symptoms. Its core antihistamine function addresses the body's internal release of histamine, which is the key chemical mediator responsible for triggering symptoms like itching, watery eyes, and sneezing. By temporarily blocking histamine activity, the medicine helps to modulate and reduce the body's immediate, excessive response to an allergen.

What side effects are possible with Dexil?

Possible Side Effects and Safety Information

The safety profile of Dexil (Dexchlorpheniramine Maleate) is characterized by a range of officially documented adverse reactions, which are classified by the physiological system affected and reported frequency.

System-Organ Classification of Adverse Reactions

The most common documented adverse reactions involve the Nervous System and are generally described as drowsiness (sedation), dizziness, and fatigue. These reactions define the expected safety profile of this first-generation H1 antagonist class. Other effects involving the nervous system include confusion, tremor, and, in rare instances, convulsions.

The drug's anticholinergic properties result in common effects on the Gastrointestinal System, such as dryness of mouth and throat, nausea, and constipation. Ophthalmic effects, including blurred vision, and Genitourinary effects, such as urinary retention, are also documented.

Serious and Population-Specific Safety Information

Rare but serious adverse reactions listed in regulatory documents include anaphylactic shock and specific blood dyscrasias, such as agranulocytosis and hemolytic anemia.

The official labeling notes specific safety considerations for certain patient populations:

  • Older Adults may experience a greater likelihood of dizziness, sedation, and hypotension.
  • Children may paradoxically experience excitation or, in cases of overexposure, convulsions.
  • Use is formally contraindicated in newborns, premature infants, and nursing mothers due to the potential for increased risk of adverse effects.

Safety limitations also relate to pre-existing conditions, requiring caution in individuals with conditions sensitive to anticholinergic effects, such as narrow-angle glaucoma and prostatic hypertrophy.

Overdose and Emergency Response

Overdose and when to seek help

In the event of a suspected or actual overdose of Dexchlorpheniramine Maleate (Dexil), immediate medical attention is required, as explicitly stated in regulatory documents. Individuals must contact emergency services or a local Poisons Information Center without delay, even in the absence of obvious symptoms.

Overdose presentations are officially documented to involve severe central nervous system (CNS) and anticholinergic toxicity. CNS manifestations exhibit a dual nature: this includes severe depression leading to extreme sleepiness, confusion, or coma, and pronounced stimulation such as excitement, tremors, hallucinations, and generalized seizures. Peripheral signs cited include blurred vision, dilated pupils, dry mouth, flushing, and high body temperature (hyperpyrexia).

Life-threatening outcomes officially listed are cardiorespiratory collapse, respiratory failure, and serious cardiovascular effects like pronounced hypotension or tachycardia. Immediate medical help is mandated when severe symptoms—such as seizures or trouble breathing—occur. Management involves symptomatic and supportive treatment, often requiring hospitalization for continuous observation, including cardiac monitoring until stabilization. Regulatory information notes that CNS stimulation is documented as being more prominent in children and the elderly following an overdose.

Therapeutic Uses of Dexil

What Dexil Treats: Main Uses and Benefits

Dexil is a medication used for symptomatic relief across various allergic contexts. It is applied across domains where additional symptomatic support is needed for conditions involving inflammatory or irritative processes, such as allergic rhinitis (hay fever), allergic conjunctivitis, and skin manifestations like urticaria (hives) and allergic dermatitis. Within these contexts, it is generally used for managing distressing symptoms.

It helps address symptom clusters affecting the nose, eyes, and skin, including frequent sneezing, rhinorrhea (runny nose), and pervasive pruritus (itching). The medication is often used during phases when symptoms become more noticeable from environmental triggers or seasonal changes, and is relevant for both adult and pediatric patients.

“It provides supportive relief that supports patients during difficult episodes by easing distress, assisting with maintaining functional stability during acute episodes.”

This supportive benefit helps ease the overall symptom burden and contributes to easing the overall symptom load.

Quick Fact: Symptomatic Relief Domains
Dexil is commonly used in situations involving heightened physiological activity to help with symptoms related to inflammatory or irritative states like allergic itching and associated localized swelling.

Eligibility and Restrictions for Use

Who Can and Cannot Use Dexil?

Dexil (Dexchlorpheniramine Maleate) eligibility is officially defined by regulatory authorities through specific inclusion and exclusion criteria.

Populations for Whom Use is Allowed and Not Recommended

Use is established for adults and children 6 years of age and older under standard labeled conditions. Conversely, use is not recommended for treating lower respiratory tract symptoms, including asthma, as officially stated in prescribing information.

Contraindications and Restrictions

Use of Dexil is contraindicated (absolutely prohibited) for newborn and premature infants and for nursing or breastfeeding mothers. The medicine is also strictly contraindicated in any patient with a known hypersensitivity to the drug or other chemically related antihistamines. An absolute prohibition applies to patients currently receiving or recently (within 14 days) treated with Monoamine Oxidase Inhibitor (MAOI) therapy.

Conditional Use and Caution

Regulatory documents mandate use with caution for elderly patients (age 60 and older) and individuals with certain underlying conditions, including narrow-angle glaucoma, symptomatic prostatic hypertrophy, bladder neck obstruction, or hyperthyroidism. Caution is also required for patients with severe hepatic or renal impairment.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Dexil

Interaction Scope

  • Medicinal product categories with documented interactions: Monoamine Oxidase Inhibitors (MAOIs), Central Nervous System (CNS) Depressants, Other Anticholinergic Agents, Other Antihistamines, Potent CYP2D6 Inhibitors.
  • Specific interacting medicines (if explicitly listed): MAOIs, Alcohol (Ethanol), Cannabis.
  • Mechanistic basis of interactions (only if stated in label): Inhibited Metabolic Clearance (pharmacokinetic), Additive Pharmacodynamic Effect (CNS depression, anticholinergic effects).
  • Timing-based interaction rules (if applicable): Must not be administered within 14 days of stopping MAOI therapy.
  • Population-specific interaction notes (if applicable): The elderly population may face increased sensitivity to the sedative and anticholinergic effects. Patients with hepatic or renal impairment have an increased risk of accumulation due to reduced clearance.
  • Interaction-related restrictions: Co-administration with MAOIs is strictly prohibited. Co-administration with other antihistamines and alcohol is officially restricted.

Interaction Classifications (High-Level)

  • Interaction severity classification (as defined in official documents): Contraindicated Combinations (MAOIs), Clinically Significant Interactions (CNS Depressants, Alcohol).
  • Regulatory basis (EMA / FDA / etc.): Based on official prescribing information and drug monographs from authorities including the FDA and NIH.
  • Interaction-context constraints (as defined in official documents): Absolute prohibition for MAOIs; caution for additive CNS depression.

Resulting Interaction Structure

  • Official interaction statements:
    • Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated due to inhibited metabolic clearance.
    • Co-administration with CNS Depressants results in additive CNS depression and is subject to official caution.
    • The drug’s clearance is susceptible to inhibition by potent CYP2D6 inhibitors, leading to increased systemic exposure.
    • The use of alcohol or cannabis while taking Dexil is officially noted as resulting in an additive CNS depressant effect.

Connection to the overall interaction profile (2–4 sentences): Official regulatory documents define Dexil’s interaction structure primarily through two restrictive categories: contraindication due to metabolic inhibition by MAOIs and mandatory use-with-caution for other drug classes and substances that cause additive CNS depression. This profile necessitates specific labeling warnings concerning substances that affect the drug’s primary metabolic pathway or amplify its established pharmacodynamic effect.

Mechanism of Action

Competitive Blockade of Peripheral H1 Receptors

Dexchlorpheniramine's primary mechanism involves acting as a competitive antagonist at the peripheral Histamine H1 receptor. This action involves the molecule binding to the receptor site on effector cells in the vascular system and respiratory tract, preventing the endogenous mediator, Histamine, from activating the cell. By interrupting the histamine-driven molecular cascade, the drug modifies the physiological responses that increase capillary permeability, thereby inhibiting fluid leakage into the interstitial space and modulating capillary function.

Modulation of Central and Autonomic Pathways

The molecule's chemical structure allows it to cross the blood-brain barrier, and it subsequently modulates pathways within the Central Nervous System (CNS) through both H1 and secondary Muscarinic Acetylcholine Receptor ( mAChR) antagonism. This dual central activity influences neural signaling associated with arousal and motor activity. Peripherally, the mAChR blockade acts on the autonomic nervous system, leading to the inhibition of secretions from glandular tissues.

Dosage and Administration Information

Official Administration Guidelines

Dexil (Dexchlorpheniramine Maleate) is administered exclusively via the oral route, available as Immediate-Release (IR) tablets, syrup, and Extended-Release (ER) tablets. Usage patterns are established to ensure standardized administration and appropriate form handling.


Labeled Dosing and Frequency

Population Immediate-Release (IR) Regimen Extended-Release (ER) Regimen
Adults (ge 12 years) 2 mg every 4 to 6 hours 4 mg or 6 mg every 8 to 12 hours
Children 6–11 years 1 mg every 4 to 6 hours 4 mg at bedtime
Children 2–5 years 0.5 mg every 4 to 6 hours ER forms are not approved

The overall administration is categorized as intermittent and typically used on an as-needed basis for symptomatic periods. For IR forms in adults, the prescribed frequency implies a maximum of up to 12 mg in a 24-hour period. Older adults may require less frequent administration or the use of the lower end of the dosing range.


Specific Use Conditions

Condition Official Instruction
Timing in Relation to Meals May be taken with or without food
Preparation Liquid forms must be measured with an accurate milliliter measuring device
Special Handling Extended-Release tablets must be swallowed whole and must not be crushed, chewed, or broken
Missed Dose Rule If a regular dose is missed, skip it if the next scheduled dose is near, and do not take a double dose.

This structure establishes the required oral delivery, mandates form-specific procedural steps like swallowing ER tablets intact, and defines precise dosage schedules for distinct age groups. This ensures the medicine is used according to the standardized protocol.

Recent Clinical Evidence

Research evidence / Overview of Studies for Dexil

Research has explored Dexil in studies concerning common allergic symptoms. Studies in this area primarily examine patient-reported outcomes describing perceived discomfort and how these outcomes related to physical discomfort changed over short time frames. The evidence contributes to the broader evidence landscape by providing context on its short-term use in conditions characterized by fluctuating or episodic manifestations.


Evidence for Use in Allergic Rhinitis (Hay Fever)

Research exploring Dexil in allergic rhinitis—a condition involving periods of heightened symptoms such as hay fever—has largely consisted of short-term Randomized Controlled Trials (RCTs) and comparative studies. These trials research examined how symptoms evolved in the observed populations, specifically looking at changes in sneezing, runny nose, and itching of the nose and eyes. Studies were conducted during periods of increased symptom activity, and research reports monitoring of symptoms.

Findings describe patterns observed in the studies, where patients' reports of outcomes related to systemic or functional imbalance were monitored during the research. The follow-up durations were limited in many of these core studies, meaning the data provide limited information for long-term outcomes when exploring persistent or chronic allergic rhinitis.


Evidence for Use in Urticaria and Allergic Skin Symptoms

Research explored Dexil in clinical situations related to skin conditions, including hives (urticaria) and allergic itching (pruritus). The research explored short-term symptom changes, focusing on outcomes linked to inflammatory or irritative states. Evaluations in clinical trials studies monitored changes in the severity of itching and the appearance of skin welts. Findings describe patterns observed in the studies that were confined to the acute phase of these episodic or acute changes.

What is Still Uncertain About Dexil

Based on regulatory and scientific reviews, research highlights what is known—and what is still uncertain—about this medicine. A key limitation is that comparative evidence is lacking in large-scale, modern RCTs that directly compare Dexil against the newest, non-sedating second-generation antihistamines. The evidence quality varies across studies, with much of the definitive data being historical.

Furthermore, information on symptom patterns over the long term is not fully established, particularly concerning non-acute, continuous use, and research provides limited insight into long-term outcomes related to systemic or functional imbalance. The study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Dexil (FAQ)


Q: What should I do if I miss a dose of Dexil? (Seeking non-directive general guidance)

Official instructions state that if a dose is missed, checking the proximity of the next scheduled dose is advised. If the next dose is near, the official guidance indicates the missed dose should be skipped.

It is officially advised not to double the dose to compensate for the missed amount.


Q: What is the regulatory status of Dexil in different regions (e.g., US, Europe)?

Dexil is defined by regulatory bodies like the FDA in the United States, as well as similar government health authorities across regions like Europe. These authorities are responsible for issuing the official documentation that details the drug's approved uses, safety profile, and usage restrictions.


Q: Does Dexil have a sedative effect that could affect driving or operating machinery?

Official warnings caution that the medicine may cause drowsiness, dizziness, or fatigue. Engaging in activities that require mental alertness, such as driving a car or operating complex machinery, should be approached with awareness of this effect, consistent with the official warnings.


Q: Does Dexil affect sleep patterns?

The official safety profile for the drug lists both sedation and sleepiness, which are common central nervous system effects of this class of medicine. Paradoxically, central nervous system effects like insomnia (difficulty sleeping) are also officially documented.


Q: How long does it usually take to feel the effects of Dexil?

The time until the drug begins to demonstrate its intended effect is described in clinical reports and pharmacokinetic data. The onset of action is generally reported to occur within one to three hours following oral administration.


Q: Is it normal to feel a change in energy levels when starting Dexil?

The drug’s established safety profile includes documented adverse reactions that may affect the nervous system, such as fatigue, as well as instances of restlessness or excitation. These represent potential changes in energy levels.


Q: Is there a generic version of Dexil available?

The active ingredient in Dexil is Dexchlorpheniramine Maleate. This substance is manufactured and available under various proprietary (brand) names and non-proprietary (generic) product labels, in addition to the proprietary name.


Q: Does Dexil have any known food or drink restrictions (like grapefruit or alcohol)?

Official warnings advise that the drug has additive depressant effects when combined with alcohol. Official documents state that alcoholic beverages should be avoided during use, consistent with the official warnings about additive effects.


Q: What does official research say about the effectiveness of Dexil?

Research reports indicate that studies have focused on examining symptomatic relief in patients with common allergies. These studies typically looked at changes in patient-reported outcomes like sneezing, runny nose, and itching of the nose and eyes.


Q: Do any official sources mention a risk of allergic reaction to Dexil?

Official labeling documents note that rare but severe adverse reactions can include hypersensitivity responses. This includes documented instances of anaphylactic shock.


Q: Is there a black box warning associated with Dexil in the United States?

Based on a review of official U.S. regulatory labeling, there is no requirement for the manufacturer to include a Black Box Warning for this medicine. This is a specific type of warning mandated for certain serious safety concerns.


Q: How quickly does Dexil leave the body after I stop taking it?

Official pharmacokinetic data describes how the body processes the drug. The half-life elimination of the drug in adults is typically reported to range between 20 to 30 hours.


Q: What should I watch out for that indicates Dexil is starting to work?

The medicine’s therapeutic role is to provide symptomatic relief, which is often observed as a reduction in the physical manifestations of common allergies, such as sneezing, watery eyes, and itching. This is based on the drug's intended function.


Q: What is the relationship between Dexil and its [potential other drug name] counterpart?

Official descriptions define the active ingredient as the isolated dextrorotatory isomer of the older substance, chlorpheniramine. This means the active ingredient is a specific single-entity chemical form related to the prior compound.


Q: Can Dexil cause changes in mood or behavior?

The official safety profile lists several adverse reactions related to the central nervous system. These documented effects include confusion, restlessness, excitation, irritability, and euphoria.


Q: What is meant by the 'half-life' of Dexil in the body?

In the context of drug science, "half-life" is a pharmacokinetic term that describes the time it takes for the amount of the active substance in the body to decrease by half. This measurement is used to understand a drug's presence and duration in the body.


Q: Can Dexil be taken by people with kidney problems?

Regulatory documents state that use requires caution in patients who have severe renal impairment (kidney damage). This caution is due to the possibility of reduced clearance of the drug, which is the official reason for mandated caution.


Q: What are the official recommendations regarding alcohol use while taking Dexil?

Official documents explicitly note that this drug has additive depressant effects when combined with alcohol. For this reason, official guidance states that alcoholic beverages should be avoided during use.


Q: Is it necessary to take Dexil exactly at the same time every day?

The medicine's overall administration is categorized in official documents as intermittent, often used on an 'as-needed' basis for symptomatic periods. This categorization indicates that the need for a precise daily time may be guided by the presence of symptoms, rather than a requirement for constant daily consistency.


Q: Does Dexil have a risk of hepatotoxicity (liver damage)?

Regulatory documents note that caution is required for use in patients with severe hepatic impairment (liver damage). This warning is related to the drug's clearance, where reduced liver function could potentially lead to increased drug accumulation in the body.


Q: Is Dexil often used as a 'first-line' treatment for its main indication?

While official labeling does not classify the drug as 'first-line,' certain official guidance for specific populations, such as older adults, indicates that nonanticholinergic antihistamines may be considered before the use of this drug class. This relates to established safety considerations.

How should Dexil be stored and disposed of?

Storage Requirements

Dexil (Dexchlorpheniramine Maleate) must be stored at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F), as designated by regulatory labeling. The medication must be kept away from excess heat and moisture; therefore, storage in environments such as bathrooms or near sinks is prohibited. Liquid formulations must be kept in a tight, light-resistant container. Tablets should be kept in their original blister pack until the time of use to ensure stability. The product must be securely stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Dexil should be disposed of by consulting a pharmacist or utilizing an official drug take-back program. If household disposal is necessary, the medicine should be mixed with an undesirable substance (like coffee grounds or kitty litter), sealed in a container, and discarded in the trash. The medication must not be poured into drains or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dexil found in:

A-Z Index: